Viridian Therapeutics, Inc.\DE·4

Apr 9, 4:26 PM ET

Ajer Jeffrey Robert 4

4 · Viridian Therapeutics, Inc.\DE · Filed Apr 9, 2025

Insider Transaction Report

Form 4
Period: 2025-04-07
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-07+42,00042,000 total
    Exercise: $11.78Exp: 2035-04-07Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4